5-1279341-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_198253.3(TERT):c.2080G>A(p.Val694Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000379 in 1,584,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V694E) has been classified as Uncertain significance.
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.2080G>A | p.Val694Met | missense_variant | 5/16 | ENST00000310581.10 | |
TERT | NM_001193376.3 | c.2080G>A | p.Val694Met | missense_variant | 5/15 | ||
TERT | NR_149162.3 | n.2159G>A | non_coding_transcript_exon_variant | 5/13 | |||
TERT | NR_149163.3 | n.2159G>A | non_coding_transcript_exon_variant | 5/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TERT | ENST00000310581.10 | c.2080G>A | p.Val694Met | missense_variant | 5/16 | 1 | NM_198253.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000349 AC: 5AN: 1432078Hom.: 0 Cov.: 33 AF XY: 0.00000282 AC XY: 2AN XY: 709868
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74334
ClinVar
Submissions by phenotype
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 08, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 694 of the TERT protein (p.Val694Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of TERT-related conditions (PMID: 15814878, 18635888; Invitae). ClinVar contains an entry for this variant (Variation ID: 12731). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TERT protein function. Experimental studies have shown that this missense change affects TERT function (PMID: 15814878, 23901009). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Pulmonary fibrosis Pathogenic:1
Likely risk allele, no assertion criteria provided | research | Garcia Pulmonary Genetics Research Laboratory, Columbia University Irving Medical Center | Jun 09, 2022 | Leukocyte telomere length (by qPCR) less than 10th percentile age-adjusted - |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 07, 2005 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 16990594, 25906514, 20502709, 23618685, 23538340, 16207588, 17825470, 20044353, 23901009, 25244922, 19636400, 19760749, 15814878, 18635888, 23716176, 20301779, 34019641, 31943309, 36496180) - |
Dyskeratosis congenita Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2016 | The p.V694M variant (also known as c.2080G>A), located in coding exon 5 of the TERT gene, results from a G to A substitution at nucleotide position 2080. The valine at codon 694 is replaced by methionine, an amino acid with highly similar properties. This alteration was first identified in a 34-year old male with moderate aplastic anemia, a family history of myelodysplastic syndrome, and markedly shortened telomeres in peripheral-blood leukocytes (Yamaguchi H et al. N. Engl. J. Med. 2005; 352:1413-24). This alteration has also been observed in an individual with idiopathic pulmonary fibrosis (Cronkhite JT et al. Am. J. Respir. Crit. Care Med. 2008; 178:729-37). Functional studies have found this variant to cause a reduction in telomerase activity when compared to wild type; however, processivity was not affected or increased when compared to wild type (Xie M et al. Nucleic Acids Res. 2010; 38:1982-96, 5:e10680, Zaug AJ et al. Nucleic Acids Res. 2013; 41:8969-78). This variant was previously reported in the SNPDatabase as rs121918662. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
TERT-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 28, 2022 | The TERT c.2080G>A variant is predicted to result in the amino acid substitution p.Val694Met. This variant was reported in an individual with aplastic anemia and shortened telomeres and a family history of myelodysplastic syndrome (Yamaguchi et al. 2005. PubMed ID: 15814878). This variant has also been reported in an individual with a personal and family history of pulmonary fibrosis (Cronkhite et al. 2008. PubMed ID: 18635888). Functional studies found this variant resulted in decreased telomerase activity; however, studies disagreed as to the extent of the decrease ranging from <1% to ~40% compared to wild type (Yamaguchi et al. 2005. PubMed ID: 15814878; Zaug et al. 2013. PubMed ID: 23901009). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Aplastic anemia Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at